Cargando…

Examining trends in cardiovascular disease mortality across Europe: how does the introduction of a new European Standard Population affect the description of the relative burden of cardiovascular disease?

BACKGROUND: Some mortality statistics are misleading when comparing between countries due to varying age distributions in their populations. In order to adjust for these differences, age-standardised mortality rates (ASMRs) are often produced. ASMRs allow for comparisons between countries as if both...

Descripción completa

Detalles Bibliográficos
Autores principales: Tadayon, Shiva, Wickramasinghe, Kremlin, Townsend, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543561/
https://www.ncbi.nlm.nih.gov/pubmed/31146761
http://dx.doi.org/10.1186/s12963-019-0187-7
_version_ 1783423099860942848
author Tadayon, Shiva
Wickramasinghe, Kremlin
Townsend, Nick
author_facet Tadayon, Shiva
Wickramasinghe, Kremlin
Townsend, Nick
author_sort Tadayon, Shiva
collection PubMed
description BACKGROUND: Some mortality statistics are misleading when comparing between countries due to varying age distributions in their populations. In order to adjust for these differences, age-standardised mortality rates (ASMRs) are often produced. ASMRs allow for comparisons between countries as if both had the same standardised population. We examined whether the updating of the standard population for Europe affected the description of the relative burden between countries in cardiovascular disease (CVD) mortality across the continent. METHODS: Mortality and population data were obtained from the World Health Organization (WHO) mortality database. ASMRs were calculated using the direct method and two European Standard Populations (ESP): 1976 ESP and 2013 ESP. We investigated differences in ASMR76 (calculated using 1976 ESP) and ASMR13 (calculated using 2013 ESP), changes in rankings of countries between the two ASMRs and differences in trends in CVD mortality in each country for the two ASMRs. RESULTS: CVD rates calculated using the 1976 ESP were on average half the size of rates calculated using the 2013 ESP. Spearman’s rank coefficient showed that the ranks of countries by ASMRs calculated using the two ESPs were different for both sexes. Joinpoint analyses showed no difference in the direction of trend between ASMR76 and ASMR13 although differences in the magnitude of the change were found in some countries. CONCLUSION: ASMRs are commonly used in studying the epidemiology of a disease. It is crucial that policy makers understand the effect of changes in standard populations on these rates. This includes how populations with different age distributions compare to each other. Similar effects may be seen in other diseases that are also more prevalent in older age groups, such as cancer and dementia.
format Online
Article
Text
id pubmed-6543561
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65435612019-06-04 Examining trends in cardiovascular disease mortality across Europe: how does the introduction of a new European Standard Population affect the description of the relative burden of cardiovascular disease? Tadayon, Shiva Wickramasinghe, Kremlin Townsend, Nick Popul Health Metr Research BACKGROUND: Some mortality statistics are misleading when comparing between countries due to varying age distributions in their populations. In order to adjust for these differences, age-standardised mortality rates (ASMRs) are often produced. ASMRs allow for comparisons between countries as if both had the same standardised population. We examined whether the updating of the standard population for Europe affected the description of the relative burden between countries in cardiovascular disease (CVD) mortality across the continent. METHODS: Mortality and population data were obtained from the World Health Organization (WHO) mortality database. ASMRs were calculated using the direct method and two European Standard Populations (ESP): 1976 ESP and 2013 ESP. We investigated differences in ASMR76 (calculated using 1976 ESP) and ASMR13 (calculated using 2013 ESP), changes in rankings of countries between the two ASMRs and differences in trends in CVD mortality in each country for the two ASMRs. RESULTS: CVD rates calculated using the 1976 ESP were on average half the size of rates calculated using the 2013 ESP. Spearman’s rank coefficient showed that the ranks of countries by ASMRs calculated using the two ESPs were different for both sexes. Joinpoint analyses showed no difference in the direction of trend between ASMR76 and ASMR13 although differences in the magnitude of the change were found in some countries. CONCLUSION: ASMRs are commonly used in studying the epidemiology of a disease. It is crucial that policy makers understand the effect of changes in standard populations on these rates. This includes how populations with different age distributions compare to each other. Similar effects may be seen in other diseases that are also more prevalent in older age groups, such as cancer and dementia. BioMed Central 2019-05-30 /pmc/articles/PMC6543561/ /pubmed/31146761 http://dx.doi.org/10.1186/s12963-019-0187-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Tadayon, Shiva
Wickramasinghe, Kremlin
Townsend, Nick
Examining trends in cardiovascular disease mortality across Europe: how does the introduction of a new European Standard Population affect the description of the relative burden of cardiovascular disease?
title Examining trends in cardiovascular disease mortality across Europe: how does the introduction of a new European Standard Population affect the description of the relative burden of cardiovascular disease?
title_full Examining trends in cardiovascular disease mortality across Europe: how does the introduction of a new European Standard Population affect the description of the relative burden of cardiovascular disease?
title_fullStr Examining trends in cardiovascular disease mortality across Europe: how does the introduction of a new European Standard Population affect the description of the relative burden of cardiovascular disease?
title_full_unstemmed Examining trends in cardiovascular disease mortality across Europe: how does the introduction of a new European Standard Population affect the description of the relative burden of cardiovascular disease?
title_short Examining trends in cardiovascular disease mortality across Europe: how does the introduction of a new European Standard Population affect the description of the relative burden of cardiovascular disease?
title_sort examining trends in cardiovascular disease mortality across europe: how does the introduction of a new european standard population affect the description of the relative burden of cardiovascular disease?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543561/
https://www.ncbi.nlm.nih.gov/pubmed/31146761
http://dx.doi.org/10.1186/s12963-019-0187-7
work_keys_str_mv AT tadayonshiva examiningtrendsincardiovasculardiseasemortalityacrosseuropehowdoestheintroductionofaneweuropeanstandardpopulationaffectthedescriptionoftherelativeburdenofcardiovasculardisease
AT wickramasinghekremlin examiningtrendsincardiovasculardiseasemortalityacrosseuropehowdoestheintroductionofaneweuropeanstandardpopulationaffectthedescriptionoftherelativeburdenofcardiovasculardisease
AT townsendnick examiningtrendsincardiovasculardiseasemortalityacrosseuropehowdoestheintroductionofaneweuropeanstandardpopulationaffectthedescriptionoftherelativeburdenofcardiovasculardisease